Raymond James & Associates’s FT Vest US Equity Deep Buffer ETF March DMAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$3.87M Sell
103,657
-4,202
-4% -$153K ﹤0.01% 1829
2024
Q2
$3.88M Buy
107,859
+99,208
+1,147% +$3.47M ﹤0.01% 1767
2024
Q1
$302K Buy
+8,651
New +$296K ﹤0.01% 3372
2023
Q3
Sell
-31,216
Closed -$1.01M 3824
2023
Q2
$1.01M Buy
31,216
+1,238
+4% +$38.9K ﹤0.01% 2469
2023
Q1
$926K Sell
29,978
-12,298
-29% -$373K ﹤0.01% 2497
2022
Q4
$1.28M Sell
42,276
-13,500
-24% -$406K ﹤0.01% 2290
2022
Q3
$1.64M Sell
55,776
-1,703
-3% -$51.9K ﹤0.01% 2098
2022
Q2
$1.71M Buy
57,479
+18,425
+47% +$570K ﹤0.01% 2082
2022
Q1
$1.26M Buy
+39,054
New +$1.24M ﹤0.01% 2446

Other funds holding DMAR

Raymond James & Associates's DMAR Position: Q3 2024 in Review

Raymond James & Associates reduced its FT Vest US Equity Deep Buffer ETF March (DMAR) stake by 3.9% in Q3 2024, selling an estimated $153K and leaving 103,657 shares worth $3.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1829.

Raymond James & Associates first reported a position in DMAR in Q1 2022 and has held it in 9 quarters since. The position peaked at $3.88M in Q2 2024. 87 funds tracked by Wall St. Rank hold DMAR as of Q3 2024.

  • Raymond James & Associates held 103,657 shares of FT Vest US Equity Deep Buffer ETF March worth $3.87M as of Q3 2024.
  • Raymond James & Associates sold 4,202 FT Vest US Equity Deep Buffer ETF March shares in Q3 2024, an estimated $153K.
  • FT Vest US Equity Deep Buffer ETF March made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1829 holding.
  • Raymond James & Associates first reported a position in FT Vest US Equity Deep Buffer ETF March in Q1 2022 and has held it in 9 quarters since.
  • Raymond James & Associates's FT Vest US Equity Deep Buffer ETF March position peaked at $3.88M in Q2 2024.
  • 87 funds tracked by Wall St. Rank held FT Vest US Equity Deep Buffer ETF March as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.